Evidence map›Paper›PMID 30219072›Full record

ReviewPediatric rheumatology online journal2018

Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol.

Casper G Schoemaker, Wineke Armbrust, Joost F Swart, Sebastiaan J Vastert, Jorg van Loosdregt, Anouk Verwoerd, Caroline Whiting, Katherine Cowan, Wendy Olsder, Els Versluis and 15 more

Abstract readReview
In one paragraph

Review in Pediatric rheumatology online journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Casper G SchoemakerPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands. C.G.Schoemaker-3@umcutrecht.nl.ORCID http://orcid.org/0000-0002-9547-0616
Wineke ArmbrustUniversity Medical Center Groningen (UMCG), Beatrix Childrens Hospital, Dept Pediatric Rheumatology and Immunology, University of Groningen, Groningen, The Netherlands.
Joost F SwartPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Sebastiaan J VastertPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Jorg van LoosdregtPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Anouk VerwoerdPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Caroline WhitingJames Lind Alliance, National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC), based at the University of Southampton, Southampton, UK.
Katherine CowanJames Lind Alliance, National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC), based at the University of Southampton, Southampton, UK.
Wendy OlsderYouth-R-Well.com, Young Patient Organisation, The Netherlands, member of EULAR PARE, Amsterdam, The Netherlands.
Els VersluisNetherlands JIA Patient and Parent Organisation, member of ENCA, Amsterdam, The Netherlands.
Rens van VlietPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Marlous J FernhoutPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Sanne L BookelmanNetherlands JIA Patient and Parent Organisation, member of ENCA, Amsterdam, The Netherlands.
Jeannette CapponReade, Centre for Rehabilitation and Rheumatology, Department Rehabilitation, Amsterdam, The Netherlands.
J Merlijn van den BergDutch Association for Pediatric Rheumatology, Amsterdam, The Netherlands.
Ellen SchatorjéDutch Association for Pediatric Rheumatology, Amsterdam, The Netherlands.
Petra C E Hissink MullerDutch Association for Pediatric Rheumatology, Amsterdam, The Netherlands.
Sylvia KamphuisDutch Association for Pediatric Rheumatology, Amsterdam, The Netherlands.
Joke de BoerFaculty of Medicine, Utrecht University, Utrecht, The Netherlands.
Otto T H M LelieveldDutch Health Professionals in Pediatric Rheumatology (DHPPR), Amsterdam, The Netherlands.
Janjaap van der NetFaculty of Medicine, Utrecht University, Utrecht, The Netherlands.
Karin R JongsmaJulius Center for Health Sciences and Primary Care Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
Annemiek van RensenPGOsupport, Dutch Networking Organisation for Patient Organisations, Utrecht, The Netherlands.
Christine DeddingDepartment of Medical Humanities, Amsterdam UMC, Amsterdam, The Netherlands.
Nico M WulffraatPediatric Rheumatology and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on Juvenile Idiopathic Arthritis (JIA) should support patients, caregivers/parents (carers) and clinicians to make important decisions in the consulting room and eventually to improve the lives of patients with JIA. Thus far these end-users of JIA-research have rarely been involved in the prioritisation of future research. MAIN BODY: Dutch organisations of patients, carers and clinicians will collaboratively develop a research agenda for JIA, following the James Lind Alliance (JLA) methodology. In a 'Priority Setting Partnership' (PSP), they will gradually establish a top 10 list of the most important unanswered research questions for JIA. In this process the input from clinicians, patients and their carers will be equally valued. Additionally, focus groups will be organised to involve young people with JIA. The involvement of all contributors will be monitored and evaluated. In this manner, the project will contribute to the growing body of literature on how to involve young people in agenda setting in a meaningful way.

conclusionA JIA research agenda established through the JLA method and thus co-created by patients, carers and clinicians will inform researchers and research funders about the most important research questions for JIA. This will lead to research that really matters.

Indexed as

AdolescentArthritis, JuvenileBiomedical ResearchCaregiversChildCooperative BehaviorDecision MakingFocus GroupsHumansNetherlandsPatient ParticipationPhysiciansResearch DesignJames Lind AllianceJuvenile Idiopathic Arthritis (JIA)Patient involvementResearch agenda

Identifiers

PMID30219072
PMCPMC6139167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.